Meiyi Mo

Title: Meiyi Mo: Innovator in Milbemycin Production

Introduction

Meiyi Mo is a notable inventor based in Taizhou, China. He has made significant contributions to the field of microbiology and pharmaceuticals, particularly in the production of milbemycin compounds. With a total of two patents to his name, Mo's work has implications for agricultural and medicinal applications.

Latest Patents

Mo's latest patents include innovative methods for producing milbemycin A4 and milbemycin A3. The first patent involves a strain of Streptomyces, specifically HS7522, which is deposited in the China General Microbiological Culture Collection Center under accession number CGMCC No. 9671 as of September 16, 2014. The second patent features another strain, HS7523, also deposited in the same center with accession number CGMCC No. 9672 on the same date. These patents highlight Mo's expertise in utilizing microbial strains for the synthesis of important pharmaceutical compounds.

Career Highlights

Meiyi Mo is currently employed at Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to advance his research in microbiology and pharmaceutical development. His work at this prominent company has allowed him to contribute to the production of essential medications and agricultural products.

Collaborations

Mo collaborates with several talented individuals in his field, including Yun Teng and Meidong Xu. These partnerships enhance the research and development efforts at Zhejiang Hisun Pharmaceutical Co., Ltd. and contribute to the advancement of innovative solutions in the industry.

Conclusion

Meiyi Mo's contributions to the field of microbiology and his innovative patents in milbemycin production underscore his importance as an inventor. His work not only advances scientific knowledge but also has practical applications in agriculture and medicine.